ITPS Canada Achieves NATO Flight Training Europe Accreditation 
Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange and Montreal Exchange Closed for Labour Day 
Doubleview Appoints Edward Huebert as Vice President, Permitting, Regulatory & Indigenous Relations 
Focus Graphite and C4V to Evaluate Mine-to-Anode Platform Combining Lac Knife Graphite with C4V’s Green Anode Technology 
Spritzer Sparkling Invites Malaysians to ‘Reset Rasa’ This Merdeka, Rediscover the Flavours That Unite Us Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023
Company to share interim data updates from ongoing Phase 1/2 trials of INZ-701 in adults…
LIXTE Biotechnology Announces a Supported Collaborative Trial to Study LIXTE’s First-in-Class PP2A Inhibitor, LB-100, Plus GSK’s Immunotherapy, Dostarlimab, in Clear-Cell Ovarian Cancer
The Phase 1b Clinical Trial Focuses on Assessing the Safety and Efficacy of the Two-Drug…
Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea
Partnership based on a highly protective vaccine candidate identified by Evaxion’s EDEN™ platform The collaboration…
Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023
MALVERN, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
PDS Biotech Announces PDS0202 Elicits Active Neutralization of Multiple Influenza Strains in Preclinical Studies
H3N2 HAI Response Vaccination with PDS0202 Provides broadly effective HAI antibody responses (minimum 1:40 ratio)…
Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV
– Based on a novel human cytomegalovirus vector platform, VIR-1388 was designed with the goal…
Corsair Pharma Announces $23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension
SUNNYVALE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Corsair Pharma, Inc., a private biopharmaceutical company…
NewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
NAARDEN, The Netherlands and MIAMI, Sept. 20, 2023 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V….
Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023
SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced…
Portage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare Conference
WESTPORT, Conn., Sept. 20, 2023 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage…
Reflect Scientific Inc. Announces Record-Breaking Freezer Order from a $40B BioPharma Company
OREM, Utah, Sept. 20, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a pioneering…
89bio to Participate in the 2023 Cantor Global Healthcare Conference
SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical…
PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose
Main Lobby Procept BioRobotics Main Lobby Main Entrance Procept BioRobotics Main Entrance SAN JOSE, Calif.,…
Lisata Therapeutics Announces Participation in InfoSec World 2023
Gregory Berkin, Chief Information Officer of Lisata, to participate in keynote discussion on CISO leadership…
Lisata Therapeutics Announces Participation in InfoSec World 2023
Gregory Berkin, Chief Information Officer of Lisata, to participate in keynote discussion on CISO leadership…
IN8bio to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage…
Tourmaline Bio Appoints Gerhard Hagn as SVP, Head of Commercial and Business Development
NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) — Tourmaline Bio, Inc. (Tourmaline), a late-stage clinical…
Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List
RESEARCH TRIANGLE PARK, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
Oxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Mérieux as part of pure-play CDMO transformation
The information contained within this announcement is deemed by the Group to constitute inside information…
Oxford Biomedica Plc – INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
The information contained within this announcement is deemed by the Group to constitute inside information…